COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Saved in:
Bibliographic Details
Published inBlood Vol. 138; no. 18; pp. 1768 - 1773
Main Authors Roeker, Lindsey E., Eyre, Toby A., Thompson, Meghan C., Lamanna, Nicole, Coltoff, Alexander R., Davids, Matthew S., Baker, Peter O., Leslie, Lori, Rogers, Kerry A., Allan, John N., Cordoba, Raul, Lopez-Garcia, Alberto, Antic, Darko, Pagel, John M., Martinez-Calle, Nicolas, García-Marco, José Antonio, Hernández‐Rivas, Jose‐Ángel, Miras, Fatima, Coombs, Catherine C., Österborg, Anders, Hansson, Lotta, Seddon, Amanda N., López Jiménez, Javier, Wilson, Matthew R., El-Sharkawi, Dima, Wojenski, Daniel, Ma, Shuo, Munir, Talha, Valenciano, Susana, Seymour, Erlene, Barr, Paul M., Pu, Jeffrey, Patten, Piers E.M., Perini, Guilherme F., Huntington, Scott F., Parry, Helen, Sundaram, Suchitra, Skarbnik, Alan, Kamdar, Manali, Jacobs, Ryan, Walter, Harriet, Walewska, Renata, Broom, Angus, Lebowitz, Sonia, Isaac, Krista M., Portell, Craig A., Ahn, Inhye E., Ujjani, Chaitra S., Shadman, Mazyar, Skånland, Sigrid S., Chong, Elise A., Mato, Anthony R.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.11.2021
American Society of Hematology
Subjects
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Antiviral Agents - therapeutic use
COVID-19 - complications
COVID-19 - mortality
COVID-19 - therapy
COVID-19 - virology
Disease Management
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Letter to Blood
Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology
Leukemia, Lymphocytic, Chronic, B-Cell - mortality
Leukemia, Lymphocytic, Chronic, B-Cell - therapy
Leukemia, Lymphocytic, Chronic, B-Cell - virology
Male
Medicin och hälsovetenskap
Middle Aged
Prognosis
Retrospective Studies
SARS-CoV-2 - drug effects
SARS-CoV-2 - isolation & purification
Survival Rate
United States - epidemiology
United States
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-1
content type line 63
ObjectType-Correspondence-2
L.E.R. and T.A.E. contributed equally to this study.
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood.2021011841